Cargando…
Chronological Changes in Neutrophil/lymphocyte Ratio in Advanced Gastric Cancer Patients Treated with Nivolumab: a Report of Nine Cases
BACKGROUND: Nivolumab has been approved for use in advanced gastric cancer (GC) after third-line chemotherapy in Japan. However, it remains difficult to predict favorable nivolumab response before treatment. METHODS: We evaluated the clinical course with a focus on the chronological changes in neutr...
Autores principales: | Nakamura, Naohiko, Kinami, Shinichi, Fujita, Jun, Kaida, Daisuke, Tomita, Yasuto, Miyata, Takashi, Fujita, Hideto, Takamura, Hiroyuki, Ueda, Nobuhiko, Kosaka, Takeo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
West Asia Organization for Cancer Prevention
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7798180/ https://www.ncbi.nlm.nih.gov/pubmed/33112554 http://dx.doi.org/10.31557/APJCP.2020.21.10.2955 |
Ejemplares similares
-
A Case of Advanced Gastroesophageal Junction Cancer with Bulky Lymph Node Metastases Treated with Nivolumab
por: Nakamura, Naohiko, et al.
Publicado: (2020) -
The neutrophil/lymphocyte ratio as a predictor of successful conversion surgery for stage IV gastric cancer: a retrospective study
por: Nakamura, Naohiko, et al.
Publicado: (2020) -
The neutrophil/lymphocyte ratio as a predictor of peritoneal metastasis during staging laparoscopy for advanced gastric cancer: a retrospective cohort analysis
por: Nakamura, Naohiko, et al.
Publicado: (2019) -
Advanced gastric cancer with abdominal wall invasion treated with curative resection after chemotherapy: a case report
por: Nakamura, Naohiko, et al.
Publicado: (2021) -
Precision surgical approach with lymph-node dissection in early gastric cancer
por: Kinami, Shinichi, et al.
Publicado: (2019)